FSD Pharma Inc (HUGE)
0.37
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.3708
0.00 (0.00%)
After-Hours: 20:00
FSD Pharma 1 Year Total Returns (Daily): -71.32% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -71.32% |
May 02, 2024 | -72.35% |
May 01, 2024 | -73.56% |
April 30, 2024 | -72.65% |
April 29, 2024 | -70.60% |
April 26, 2024 | -66.67% |
April 25, 2024 | -68.90% |
April 24, 2024 | -70.37% |
April 23, 2024 | -70.63% |
April 22, 2024 | -69.05% |
April 19, 2024 | -69.30% |
April 18, 2024 | -71.45% |
April 17, 2024 | -73.66% |
April 16, 2024 | -73.12% |
April 15, 2024 | -71.89% |
April 12, 2024 | -70.74% |
April 11, 2024 | -67.91% |
April 10, 2024 | -67.72% |
April 09, 2024 | -64.52% |
April 08, 2024 | -63.95% |
April 05, 2024 | -59.90% |
April 04, 2024 | -57.26% |
April 03, 2024 | -57.16% |
April 02, 2024 | -56.77% |
April 01, 2024 | -55.38% |
Date | Value |
---|---|
March 28, 2024 | -54.99% |
March 27, 2024 | -54.78% |
March 26, 2024 | -52.32% |
March 25, 2024 | -54.40% |
March 22, 2024 | -56.41% |
March 21, 2024 | -54.52% |
March 20, 2024 | -50.61% |
March 19, 2024 | -50.00% |
March 18, 2024 | -49.66% |
March 15, 2024 | -45.43% |
March 14, 2024 | -48.31% |
March 13, 2024 | -46.45% |
March 12, 2024 | -47.66% |
March 11, 2024 | -46.13% |
March 08, 2024 | -43.75% |
March 07, 2024 | -39.86% |
March 06, 2024 | -42.58% |
March 05, 2024 | -42.78% |
March 04, 2024 | -40.97% |
March 01, 2024 | -46.73% |
February 29, 2024 | -50.56% |
February 28, 2024 | -48.70% |
February 27, 2024 | -44.23% |
February 26, 2024 | -43.86% |
February 23, 2024 | -46.67% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.15%
Minimum
Oct 21 2019
120.7%
Maximum
Feb 21 2023
-36.46%
Average
-46.29%
Median
Mar 30 2021
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |